Is Hikal Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Hikal Ltd (HIKAL.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Hikal Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Hikal Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Hikal Ltd?

Muslim investors may consider investing in Hikal Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Hikal Ltd classified as HALAL?

Musaffa determines the Shariah status of Hikal Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Hikal Ltd updated?

The Shariah compliance status of Hikal Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Hikal Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Hikal Ltd?

You can check the latest Shariah compliance status of Hikal Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

HIKAL.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 25, 2026

Report Source: 2026 3rd Quarter Report

Hikal Ltd. Stock Analysis HIKAL.NS

India Health Care Micro Cap Report: Q3, 2026

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, and hemorheologic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID. Its crop protection products are used in algaecide, biocide, fungicide, herbicide, insecticide, and intermediate. The company offers contract research services for synthesis, process development, and manufacturing projects.

Key Statistics of Hikal Ltd (HIKAL.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹201.00₹209.80

Today's Open

₹209.70

Volume

164.03K

P/E Ratio (TTM)

28.30

52 Week Range

₹146.25₹449.25

Market Cap

24.00B

Avg. Volume

314.55K

Dividend Yield

0.67%

Financial Metrics & Statements of Hikal Ltd (HIKAL.NS)

FAQ's for Hikal Ltd (HIKAL.NS)

According to Musaffa’s Shariah screening methodology, Hikal Ltd (HIKAL.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.